Resmed (RMD) Cash from Operations Growth (1y) (2010 - 2026)
Resmed (RMD) Cash from Operations Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.32 Bn | 121.10 Bn | 1.96 Bn | 48.31% |
| 2 | Becton Dickinson | 44.69 Bn | 43.88 Bn | 2.15 Bn | 428.92% |
| 3 | Alcon | 32.80 Bn | 31.14 Bn | 1.53 Bn | - |
| 4 | Medline | 32.72 Bn | 30.49 Bn | 1.84 Bn | -39.59% |
| 5 | Resmed | 29.54 Bn | 27.88 Bn | 890.98 Mn | -4.24% |
| 6 | West Pharmaceutical Services | 23.56 Bn | 23.13 Bn | 329.20 Mn | -29.98% |
| 7 | Solventum | 14.00 Bn | 13.44 Bn | 1.10 Bn | -751.72% |
| 8 | Cooper Companies | 13.75 Bn | 13.61 Bn | 735.40 Mn | 90.02% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 186.74% |
| 10 | Baxter International | 12.00 Bn | 9.98 Bn | 891.00 Mn | 315.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.24% |
| Dec 31, 2025 | 10.08% |
| Sep 30, 2025 | 40.48% |
| Jun 30, 2025 | 22.42% |
| Mar 31, 2025 | 43.93% |
| Dec 31, 2024 | 13.12% |
| Sep 30, 2024 | 13.71% |
| Jun 30, 2024 | 85.36% |
| Mar 31, 2024 | 42.28% |
| Dec 31, 2023 | 112.10% |
| Sep 30, 2023 | 541.00% |
| Jun 30, 2023 | 198.71% |
| Mar 31, 2023 | 140.61% |
| Dec 31, 2022 | -41.50% |
| Sep 30, 2022 | 168.02% |
| Jun 30, 2022 | -64.91% |
| Mar 31, 2022 | -40.17% |
| Dec 31, 2021 | 29.40% |
| Sep 30, 2021 | -145.60% |
| Jun 30, 2021 | -31.41% |